Immunoglobulin G complex interactions with rheumatoid factor and neutrophils: 51CrCl3 labelling and 14CO2 hexose monophosphate shunt studies.
The interactions of soluble and insoluble IgG complexes with macromolecular rheumatoid factor (RF) and neutrophils have been examined in an in vitro system allowing the separate assay of the biologic activities of these elements in the rheumatoid inflammatory process. Studies utilizing soluble and insoluble 51CrCl3 labelled human IgG complexes have demonstrated uptake of only the insoluble complexes by human neutrophils. A burst of hexose monophosphate shunt activity, as evidenced by increased oxidation of glucose-l-14C to 14CO2, has been shown to occur only when neutrophils are exposed to these insoluble complexes. High titer RF sera added to the insoluble complexes prior to their incubation with neutrophils did not affect either the uptake of the complexes or the magnitude of hexose monophosphate shunt activity. Native IgG and soluble IgG complexes were not taken up by the neutrophils and did not stimulate hexose monophosphate shunt activity in the presence or absence of rheumatoid sera. The addition of high titer RF sera to soluble IgG complexes produced precipitation of RF-IgG complexes which were capable of stimulating hexose monophosphate shunt activity in normal neutrophils. RF thus has been shown to change functionally inactive soluble complexes into functionally active insoluble complexes capable of stimulating normal neutrophils. Neutrophil stimulation by insoluble complexes may be important in the continuing inflammatory process occurring in the joints of patients with rheumatoid arthritis.
D001172:Arthritis, Rheumatoid / Q000276:immunology; D002245:Carbon Dioxide; D002860:Chromium Radioisotopes; D004347:Drug Interactions; D005947:Glucose / Q000378:metabolism; D006600:Hexosephosphates / Q000378:metabolism*; D006801:Humans; D007074:Immunoglobulin G; D066298:In Vitro Techniques; D009504:Neutrophils / Q000276:immunology* / Q000378:metabolism; D010084:Oxidation-Reduction; D010428:Pentosephosphates / Q000378:metabolism*; D012217:Rheumatoid Factor / Q000494:pharmacology*; D012995:Solubility
D002860:Chromium Radioisotopes; D006600:Hexosephosphates; D007074:Immunoglobulin G; D010428:Pentosephosphates; D002245:Carbon Dioxide; D012217:Rheumatoid Factor; D005947:Glucose